Search Results
Jun 24, 2026, 02:27 ET Creating Shareholder Value Through a Possible SEGRO and Prologis Combination
reject any proposed transaction with Prologis; (ii) uncertainties as to whether SEGRO will cooperate with Prologis regarding any proposed transaction; (iii) the effect of the announcement of any proposed transaction on the ability of Prologis and SEGRO to operate their respective businesses and retain and
More news about: Prologis, Inc.
Jun 24, 2026, 01:36 ET La Cuarta Exposición Internacional de la Cadena de Suministro de China se inaugura en Pekín
Guohua. Jennifer Jordan-Saifi, consejera delegada de la Iniciativa de Mercados Sostenibles, leyó un mensaje de felicitación de Su Majestad el Rey Carlos III del Reino Unido a la cuarta edición de la CISCE. Aproximadamente 1.300 representantes de gobiernos, empresas, instituciones académicas y organizaciones
More news about: China International Supply Chain Expo
Jun 24, 2026, 01:33 ET В Пекине открылась четвертая выставка China International Supply Chain Expo
главный исполнительный директор Инициативы по устойчивым рынкам, зачитала поздравительное послание Его Величества короля Соединенного Королевства Карла III четвертой выставке CISCE. В церемонии открытия приняли участие около 1300 представителей правительства, бизнеса, научных кругов и международных организаций
More news about: China International Supply Chain Expo
Jun 24, 2026, 01:25 ET Vierte China International Supply Chain Expo in Peking eröffnet
das Wort. Jennifer Jordan-Saifi, Geschäftsführerin der Sustainable Markets Initiative, verlas eine Glückwunschbotschaft Seiner Majestät König Charles III. des Vereinigten Königreichs zur 4. CISCE. An der Eröffnungsfeier nahmen rund 1300 Vertreter aus Politik, Wirtschaft, Wissenschaft und internationalen
More news about: China International Supply Chain Expo
Jun 23, 2026, 23:39 ET Beyond Horizons, Forward Together | Kexing Biopharm Concludes Participation in CPHI & PMEC China 2026
GB19/GB26 for systemic lupus erythematosus, GB10 for ophthalmology, and GB20/GB24 for autoimmune disorders. In addition, the clinical progress for two Phase III programs—long-acting GC and GB05 (interferon inhalation solution)—garnered significant attention.Years of steady development in technology platforms
More news about: Kexing Biopharm
Jun 23, 2026, 23:00 ET Tamron 17-70mm f/2.8 APS-C Lens for Nikon Z and Canon RF Camera Mounts; Available July 2nd and More Info at B&H
https://www.bhphotovideo.com/c/product/1981702-REG/tamron_b070r700_17_70mm_f_2_8_di_iii_a.htmlTamron 17-70mm f/2.8 Di III-A VC RXD Lens (Nikon Z)
More news about: B&H Photo
Jun 23, 2026, 19:35 ET Robbins LLP Urges BTGO Stockholders Who Lost Money Investing in BitGo Holdings, Inc. to Contact the Firm for Information About Leading the Class Action
defendants' statements regarding, inter alia, BitGo's financial performance and business prospects as a public company lacked a reasonable basis; and (iii) as a result, the Offering Documents and defendants' public statements throughout the Class Period were materially false and/or misleading and/or failed
More news about: Robbins LLP
Jun 23, 2026, 17:01 ET Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter
2026 was an excellent year for Kewaunee, particularly in light of the challenging operating environment in which it was delivered," said Thomas D. Hull III, Kewaunee's President and Chief Executive Officer. "Our team managed through these conditions effectively, maintaining a strong level of EBITDA while
More news about: Kewaunee Scientific Corporation
Jun 23, 2026, 16:00 ET GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit
since attested, the trial as executed within the three-year follow-up period was insufficient to demonstrate the achievability of a reduction in Stage III-IV cancers; defendants disclosed the trial period, and thus the screening duration, was apparently insufficient to demonstrate whether the primary endpoint
More news about: THE ROSEN LAW FIRM, P. A.
Jun 23, 2026, 15:31 ET Triển lãm Chuỗi cung ứng Quốc tế Trung Quốc lần thứ 4 khai mạc tại Bắc Kinh
biểu. Jennifer Jordan-Saifi, Giám đốc điều hành của Sáng kiến Thị trường Bền vững, đã đọc thông điệp chúc mừng của Quốc vương Vương quốc Anh Charles III gửi tới CISCE lần thứ 4. Khoảng 1.300 đại biểu đến từ chính phủ, doanh nghiệp, giới học thuật và các tổ chức quốc tế thuộc hơn 100 quốc gia và vùng lãnh
More news about: China International Supply Chain Expo
Jun 23, 2026, 12:00 ET Eide Bailly Advances Growth Strategy and Client Service Commitment Through Investment from Reverence Capital Partners
is a private investment firm focused on three complementary strategies: (i) Financial Services-Focused Private Equity, (ii) Structured Credit, and (iii) Real Estate Solutions. Today, Reverence manages in excess of $17 billion in AUM. Reverence focuses on thematic investing in leading global Financial
More news about: Reverence Capital Partners; Eide Bailly
Jun 23, 2026, 11:29 ET Fourth China International Supply Chain Expo Opens in Beijing
Jennifer Jordan-Saifi, Chief Executive Officer of the Sustainable Markets Initiative, read out a congratulatory message from His Majesty King Charles III of the United Kingdom to the fourth CISCE. Approximately 1,300 representatives from government, business, academia and international organizations across
More news about: China International Supply Chain Expo
Jun 23, 2026, 11:17 ET Fourth China International Supply Chain Expo Opens in Beijing
Jennifer Jordan-Saifi, Chief Executive Officer of the Sustainable Markets Initiative, read out a congratulatory message from His Majesty King Charles III of the United Kingdom to the fourth CISCE. Approximately 1,300 representatives from government, business, academia and international organizations across
More news about: China International Supply Chain Expo
Jun 23, 2026, 10:57 ET OVERSEAS ADVENTURE TRAVEL INTRODUCES NEW MEKONG AND CHILE ITINERARIES AS IT EXPANDS LAND-AND-SHIP FORMAT ACROSS FOUR CONTINENTS
hiking among the iconic granite spires of Torres del Paine National Park before embarking on a 5-night Chilean Fjord Cruise aboard the M/V Skorpios III, a privately chartered 90-passenger vessel. Groups are capped at no more than 16 travelers, keeping the experience intimate as glaciers calve into channels
More news about: Overseas Adventure Travel
Jun 23, 2026, 10:31 ET Non-muscle Invasive Bladder Cancer Market Dynamics to Shift During the Forecast Period (2026-2036) as Novel Targeted and Gene Therapies Enter Late-Stage Development | DelveInsight
invasive bladder cancer (NMIBC). Within the BOND-003 study, Cohort C focuses on patients with carcinoma in situ (CIS ± Ta/T1) and has progressed to Phase III clinical development, highlighting its advanced stage. Meanwhile, Cohort P is evaluating a distinct patient subgroup and remains in Phase II, representing
More news about: DelveInsight Business Research, LLP
Jun 23, 2026, 10:02 ET NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
demand for its products; (ii) in reality, Nano-X's production and manufacturing operations were poorly aligned with demand for the Company's products; (iii) as a result, Nano-X was experiencing significantly increased operating expenses and cash burn; (iv) the foregoing significantly increased the likelihood
More news about: The Gross Law Firm
Jun 23, 2026, 10:02 ET BTGO Shareholder Alert: BitGo Holdings, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm
defendants' statements regarding, inter alia, BitGo's financial performance and business prospects as a public company lacked a reasonable basis; and (iii) as a result, the offering documents and defendants' public statements throughout the Class Period were materially false and/or misleading and/or failed
More news about: The Gross Law Firm
Jun 23, 2026, 10:00 ET GRAL UPCOMING DEADLINE : The Gross Law Firm Alerts GRAIL, Inc. Stockholders of Securities Class Action - Contact the Firm
that the probability of achieving the statistical reduction in Stage III & IV cancers by the trial's end had been reduced. On February 19, 2026, GRAIL announced that the "primary endpoint of statistically significant Stage III-IV reduction was not observed" in the NHS-Galleri Trial. The Company
More news about: The Gross Law Firm
Jun 23, 2026, 10:00 ET Bernstein Litowitz Berger & Grossmann, LLP Announces Notice of Pendency of Class Action and Proposed Settlement for Investors Who Purchased or Acquired Stitch Fix, Inc. Common Stock from June 9, 2020 Through June 9, 2022
SUMMARY NOTICE OF (I) PENDENCY OF CLASS ACTION AND PROPOSED SETTLEMENT; (II) SETTLEMENT HEARING; AND (III) MOTION FOR ATTORNEYS' FEES AND LITIGATION EXPENSESTO: All persons and entities who purchased or acquired Stitch
More news about: Bernstein Litowitz Berger & Grossmann LLP
Jun 23, 2026, 10:00 ET Lost Money on Lucid Group, Inc. (LCID)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
deliveries of the Lucid Gravity; (ii) the foregoing was likely to, and did, have a material negative impact on the Company's business and financial results; (iii) accordingly, the defendants had overstated the purported enhancements to Lucid's manufacturing and delivery capabilities and overall operations; and
More news about: The Gross Law Firm
Jun 23, 2026, 10:00 ET AVAV Shareholder Alert: AeroVironment, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
ongoing efforts to modernize the Satellite Control Network; (ii) accordingly, defendants overstated AeroVironment's business and financial prospects; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: July 27, 2026 Shareholders
More news about: The Gross Law Firm
Jun 23, 2026, 10:00 ET ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm
Trio was losing significant market share to a lower priced competing canine parasiticide with broader indicated use in a slowing overall market; and (iii) Zoetis' dermatology products, Apoquel and Cytopoint, were losing substantial market share to a newly launched competing canine treatment.DEADLINE:
More news about: The Gross Law Firm
Jun 23, 2026, 10:00 ET RGC Shareholder Alert: June 23, 2026 Lead Plaintiff Deadline in Regencell Bioscience Holdings Limited Securities Class Action - Contact The Gross Law Firm
manipulation; (ii) the resulting volatility in the market for the Company's ordinary shares exposed Regencell's investors to significant financial risk; (iii) all the foregoing subjected Regencell to a heightened risk of regulatory and/or governmental scrutiny and enforcement action, as well as significant
More news about: The Gross Law Firm
Jun 23, 2026, 10:00 ET GPK Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Graphic Packaging Holding Company Securities Lawsuit - Contact The Gross Law Firm
and severity of the foregoing issues, which were likely to, and did, have a material negative impact on the Company's business and financial results; (iii) defendants likewise overstated the strength and sustainability of the Company's business model and operations, as well as its ability to weather ongoing
More news about: The Gross Law Firm
Jun 23, 2026, 10:00 ET PICS Deadline Alert: The Gross Law Firm Reminds PicS N.V. (PICS) Investors of Securities Class Action Deadline on August 4, 2026
exposures previously classified as Stage 2 to Stage 3, leading to an incremental ECL charge of R$88 million in the three months ended December 31, 2025; (iii) PicS N.V. had experienced a heightened, but unreported, Stage 3 formation rate of more than 7% in the fourth quarter of 2025 that deviated substantially
More news about: The Gross Law Firm